Publicaciones en colaboración con investigadores/as de Massachusetts General Hospital (28)

2020

  1. Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study

    ESC Heart Failure, Vol. 7, Núm. 2, pp. 559-566

2019

  1. Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy

    Circulation, Vol. 140, Núm. 1, pp. 31-41

  2. Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction

    Journal of Molecular and Cellular Cardiology, Vol. 130, pp. 216-233

2018

  1. Pulmonary Production of Soluble ST2 in Heart Failure

    Circulation. Heart failure, Vol. 11, Núm. 12, pp. e005488

2015

  1. Cystatin C-based CKD-EPI equations and N-terminal Pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure

    Clinical Cardiology, Vol. 38, Núm. 2, pp. 106-113

  2. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction

    JACC: Heart Failure, Vol. 3, Núm. 1, pp. 50-58

  3. ST2 testing for chronic heart failure therapy monitoring: The international ST2 consensus panel

    American Journal of Cardiology, Vol. 115, Núm. 7, pp. 70B-75B

  4. The biology of ST2: The international ST2 consensus panel

    American Journal of Cardiology, Vol. 115, Núm. 7, pp. 3B-7B

2014

  1. Body mass index and mortality in acutely decompensated heart failure across the world: A global obesity paradox

    Journal of the American College of Cardiology, Vol. 63, Núm. 8, pp. 778-785

  2. Galectin-3 expression in cardiac remodeling after myocardial infarction

    International Journal of Cardiology, Vol. 172, Núm. 1

  3. Modulation of IL-33/ST2 system in postinfarction heart failure: Correlation with cardiac remodelling markers

    European Journal of Clinical Investigation, Vol. 44, Núm. 7, pp. 643-651

2013

  1. Association between elevated blood glucose and outcome in acute heart failure: Results from an international observational cohort

    Journal of the American College of Cardiology, Vol. 61, Núm. 8, pp. 820-829

  2. Comparison of risk prediction with the CKD-EPI and MDRD equations in acute decompensated heart failure

    Journal of Cardiac Failure, Vol. 19, Núm. 8, pp. 583-591

  3. Heart rate control in chronic heart failure: Resting versus mean heart rate with prolonged ambulatory ECG recording

    International Journal of Cardiology, Vol. 170, Núm. 2

  4. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study

    International Journal of Cardiology, Vol. 168, Núm. 3, pp. 2186-2194

2012

  1. Highly sensitive troponin T for risk stratification of acutely destabilized heart failure

    American Heart Journal, Vol. 163, Núm. 6, pp. 1002-1010

  2. Red blood cell distribution width predicts new-onset anemia in heart failure patients

    International Journal of Cardiology, Vol. 160, Núm. 3, pp. 196-200

  3. Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure

    Cardiology (Switzerland), Vol. 122, Núm. 3, pp. 158-166

2011

  1. Eplerenone in mild heart failure

    New England Journal of Medicine

  2. Short-term variability of heart rate turbulence in chronic heart failure

    Journal of Cardiac Failure, Vol. 17, Núm. 9, pp. 735-741